Search - tctmd.com

Displaying 261 - 280 of 671

Sort: Relevancy | Date

Presentation

Endovascular Therapy for Acute Ischemic Stroke

Presenter: Partha Sardar

June 22, 2015

Presentation

Predictors of Bleeding in ACS Patients Treated With Prasugrel

Presenter: P. Widimsky

June 19, 2015

Presentation CCVVC 2015

Top 10 Advances of Interventional Cardiology 2014

Presenter: Samin K Sharma

June 17, 2015

Presentation CCVVC 2015

Data for Recent Antiplatelets and Antithrombotics

Presenter: Deepak L. Bhatt

June 17, 2015

Presentation

Concomitant PPI Use, Platelet Activity, and Clinical Outcomes in ACS Patients Treated With Prasugrel vs Clopidogrel and Managed Without Revascularization

Presenter: Jose Carlos Nicolau

June 17, 2015

Presentation

Bivalirudin Is Associated With Improved Clinical and Economic Outcomes in HF Patients Undergoing PCI

Presenter: DS. Pinto

June 08, 2015

Presentation

Association of Discharge Aspirin Dose With Outcomes After Acute MI

Presenter: Ying Xian

May 27, 2015

Presentation Fellows 2015

Case 2

Presenter: Roxana Mehran, David J. Cohen, Kevin J. Croce

May 15, 2015

Presentation Fellows 2015

Case 1

Presenter: Roxana Mehran, David J. Cohen, Robert W. Yeh

May 15, 2015

Presentation Fellows 2015

How to Navigate the New Oral Anticoagulants and Deal With Triple Therapy

Presenter: Manish A. Parikh, Roxana Mehran

May 15, 2015

Presentation Fellows 2015

Antithrombin Pharmacology for the Interventionalist

Presenter: Manish A. Parikh, Roxana Mehran, David J. Cohen

May 15, 2015

Presentation Fellows 2015

Antiplatelet Therapy for the Interventionalist

Presenter: Manish A. Parikh, Roxana Mehran, Gregg W. Stone

May 15, 2015

Presentation

PROMETHEUS: Clinical Assessment of ACS Patients Managed With PCI and Treated With Prasugrel or Clopidogrel

Presenter: Usman Baber

May 11, 2015

Presentation

Ticagrelor vs Clopidogrel in Troponin-Negative ACS Patients Undergoing Ad Hoc PCI

Presenter: Roxana Mehran

May 08, 2015

Presentation

Activated Clotting Time (ACT) and Outcomes During PCI for NSTEMI: Insights from FUTURA OASIS-8

Presenter: Gregory Ducrocq

April 24, 2015

Presentation

Duration of Triple Therapy in Patients Requiring Oral Anticoagulation After DES Implantation

Presenter: K.A. Fiedler

April 22, 2015

Presentation

Association of DAPT With Reduced Major Adverse Cardiovascular Events in Symptomatic PAD

Presenter: E.J. Armstrong

April 22, 2015

Presentation

ACC 2015 Late Breaking Trials: PCI Access and Anticoagulation Trials

Presenter: Gregg W. Stone

April 14, 2015

Presentation ARCH 2015

Acute Coronary Syndromes

Presenter: Richard G. Bach

April 10, 2015

Presentation

Antiplatelet Therapy Duration Following BMS or DES: The DAPT Randomized Clinical Trial

Presenter: D. J. Kereiakes

March 24, 2015

Advertisement

Endovascular Therapy for Acute Ischemic Stroke

Predictors of Bleeding in ACS Patients Treated With Prasugrel

Top 10 Advances of Interventional Cardiology 2014

Data for Recent Antiplatelets and Antithrombotics

Concomitant PPI Use, Platelet Activity, and Clinical Outcomes in ACS Patients Treated With Prasugrel vs Clopidogrel and Managed Without Revascularization

Bivalirudin Is Associated With Improved Clinical and Economic Outcomes in HF Patients Undergoing PCI

Association of Discharge Aspirin Dose With Outcomes After Acute MI

Case 2

Case 1

How to Navigate the New Oral Anticoagulants and Deal With Triple Therapy

Antithrombin Pharmacology for the Interventionalist

Antiplatelet Therapy for the Interventionalist

PROMETHEUS: Clinical Assessment of ACS Patients Managed With PCI and Treated With Prasugrel or Clopidogrel

Ticagrelor vs Clopidogrel in Troponin-Negative ACS Patients Undergoing Ad Hoc PCI

Activated Clotting Time (ACT) and Outcomes During PCI for NSTEMI: Insights from FUTURA OASIS-8

Duration of Triple Therapy in Patients Requiring Oral Anticoagulation After DES Implantation

Association of DAPT With Reduced Major Adverse Cardiovascular Events in Symptomatic PAD

ACC 2015 Late Breaking Trials: PCI Access and Anticoagulation Trials

Acute Coronary Syndromes

Antiplatelet Therapy Duration Following BMS or DES: The DAPT Randomized Clinical Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content